Preparation and evaluation of temozolomide loaded PLGA nanoparticles for the treatment of glioblastoma multiforme

Nature·Oct 16

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the use of nanoparticles, including those made of PLGA, to treat glioblastoma multiforme. These nanoparticles are being designed to carry chemotherapeutic agents, such as temozolomide, and may be able to cross the blood-brain barrier, potentially improving treatment outcomes. The development of these nanocarriers is part of a broader effort to engineer new strategies for treating glioblastoma using biomaterials and nanotechnology.

Full coverage

Chemotherapeutic nanoparticles for glioblastoma

Frontiers·Aug 10

Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood–brain–barrier in a glioblastoma model

Nature·Aug 22

Engineering hope: biomaterial strategies against glioblastoma

Frontiers·May 26

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma

PNAS·Jul 1

Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability

Wiley Online Library·Dec 30

Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme

Nature·Mar 29

Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases

Frontiers·Feb 5

A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles

Nature·Mar 1

View original report at Nature ↗

Fetching the latest headlines…